vitaly-gariev-2kopEHjST-g-unsplash

Real-World Examples of AI Bias in Healthcare

Posted 31 Mar 2026 · Updated 4 Aug 2026 · 5 min read

AI bias in healthcare is not theoretical. It has been documented in risk-prediction algorithms, diagnostic imaging, drug dosing, medical devices, and clinical decision support, each time producing measurable disparities in diagnosis, treatment, or outcomes. This is not a data-quality footnote; it is a systemic pattern that shows up whenever a model is trained on imperfect, unequal real-world healthcare data. Here are 7 documented cases, what caused each, and what changed once the bias was identified.

Article Summary
  • A widely studied risk-prediction algorithm used healthcare cost as a proxy for illness, systematically under-flagging sicker Black patients for extra care; correcting the proxy raised the flagged share from 17.7% to 46.5%.
  • Dermatology AI trained on datasets with as few as 10 images of brown skin and 1 image of dark skin out of 100,000+ samples shows lower sensitivity for darker skin tones.
  • Bias enters through hardware too: pulse oximeters overestimate oxygen saturation in patients with darker skin, delaying detection of low oxygen levels.
  • Bias can emerge even when race is never used as a model input, because proxy variables like cost or ZIP code encode it implicitly.
  • Bias compounds across layers, from sensors to datasets to models to clinical decisions, and eliminating it entirely is not realistic; managing the trade-offs responsibly is the actual goal.
Quick Answer
Documented AI bias in healthcare includes a risk-prediction algorithm that under-flagged sicker Black patients using cost as a proxy, dermatology AI trained on almost no dark-skin images, pulse oximeters that overestimate oxygen in darker skin, and warfarin dosing algorithms trained mostly on European genetic data. Bias enters through data, hardware, and human over-trust in AI, not just one source.

How Bias Actually Enters These Systems

Before the case studies, it helps to name the actual mechanisms, since "biased data" undersells how varied the entry points are.

Proxy Variable Bias
Non-clinical variables like cost or ZIP code stand in for clinical need, encoding inequity even without using race directly.
Representation Bias
Certain demographics are underrepresented in training datasets, degrading model performance for those groups.
Measurement Bias
Labels reflect historical inequities in care delivery rather than a patient's true clinical state.
Algorithmic Design Bias
Optimization objectives are misaligned with clinical fairness, so the model succeeds at the wrong goal.

Unlike a one-off clinical error, these biases scale across entire patient populations, which is what makes them systemic rather than episodic.

7 Documented Cases

Case 01 — Risk Prediction
Cost as a Biased Proxy for Illness Severity

The Setup

A widely deployed risk-prediction algorithm used healthcare cost as a surrogate for illness severity to identify patients for high-risk care management programs.

The Problem

Healthcare expenditure isn't a neutral variable; it reflects access disparities. A landmark study found Black patients with the same number of chronic conditions incurred $1,800 less in annual healthcare costs than white patients, so the algorithm systematically prioritized healthier white patients over sicker Black patients.

What Changed

Replacing cost with direct health indicators increased the share of Black patients flagged for extra care from 17.7% to 46.5%.

Key Insight

Bias can emerge even when sensitive attributes like race are excluded entirely, because proxy variables encode them implicitly.

Case 02 — Diagnostic Imaging
Skin Cancer Detection Failures in Dermatology AI

The Setup

Diagnostic dermatology AI systems trained on image datasets used to detect skin cancer, including melanoma.

The Problem

A study analyzing 21 datasets found only 10 images of brown skin and 1 image of dark skin out of more than 100,000 total samples. Models trained on this data show lower sensitivity and specificity for darker skin tones, increasing both false negatives (missed cancers) and false positives (unnecessary interventions).

Clinical Impact

Delayed melanoma diagnosis and increased morbidity from late-stage detection in underrepresented populations.

Key Insight

This isn't a simple data-volume problem; it reflects structural bias in clinical image collection and underrepresentation in dermatological research pipelines.

Case 03 — Drug Dosing
Warfarin Dosing and Genetic Bias

The Setup

AI-driven dosing algorithms for warfarin, an anticoagulant whose correct dose depends heavily on genetic variants that influence drug metabolism.

The Problem

Algorithms were trained primarily on European genetic data, excluding key variants more prevalent in African populations.

Clinical Impact

African American patients experienced higher rates of overdosing (supratherapeutic INR levels) and increased risk of bleeding complications.

Key Insight

Model generalization fails when real biological variability is treated as statistical noise instead of a core signal the model needs to account for.

Case 04 — Medical Devices
Pulse Oximeter Bias

The Setup

Pulse oximeters, the devices that estimate blood oxygen saturation, feeding data into downstream clinical AI systems.

The Problem

Devices overestimate oxygen saturation in patients with darker skin, delaying detection of hypoxia (dangerously low oxygen).

Clinical Impact

Studies have linked this to delayed treatment escalation, worse organ function, and increased mortality in Black patients.

Key Insight

When AI systems rely on biased sensor inputs, the bias is amplified downstream. Even a well-designed model inherits flawed measurements it has no way to detect.

Case 05 — Genomic Medicine
European-Centric Data Bias in Genomic AI

The Setup

Genomic AI models used for disease prediction and personalized treatment planning.

The Problem

Over 80% of genomic datasets come from individuals of European ancestry, reducing accuracy for non-European populations.

The Feedback Loop

Underrepresentation leads to inaccurate predictions, inaccurate predictions reduce trust and participation from affected communities, and reduced participation perpetuates the original underrepresentation.

Case 06 — Clinical Decision Support
Treatment Recommendation Bias

The Pattern

Research has documented AI clinical decision support systems recommending more aggressive treatment for white patients and more conservative approaches for Black patients with clinically similar presentations, patterns that trace back to historical treatment data the models were trained on.

The Scale of the Disparity

Overall mortality for non-Hispanic Black patients runs roughly 30% higher than for non-Hispanic white patients, a disparity that AI models trained on historical outcomes data risk reinforcing rather than correcting.

A More Recent Example

A November 2025 Cedars-Sinai study of large language models generating psychiatric treatment recommendations found explicit and implicit racial bias: some models omitted medication recommendations for ADHD when a patient's race was stated, or suggested guardianship for depression specifically when racial identifiers were present.

Technical Root Cause

Models trained on historical treatment patterns reproduce the biases embedded in those patterns, effectively reinforcement-learning from biased past clinical decisions.

Case 07 — Human Factors
Automation Bias: Over-Reliance on AI Systems

The Pattern

Not every case of AI bias originates in data. Automation bias describes clinicians over-trusting AI outputs and reducing their own critical evaluation of a recommendation simply because it came from a model.

The Implication

Even a genuinely unbiased model can cause harm if clinicians assume algorithmic infallibility and human oversight weakens as a result.

The pattern across all 7 cases: bias enters through data, through hardware, and through human behavior, not just one of the three. A fix that only addresses training data misses the pulse oximeter and automation bias cases entirely.

Cross-Cutting Patterns Across These Cases

Proxy Misalignment
Variables like cost or utilization are easier to measure than health, but they encode inequity rather than clinical need.
Data Inequality Isn't Random
Underrepresentation is systematic, not stochastic, and needs to be treated as a structural problem, not noise.
Bias Propagates Across Layers
From sensors, to datasets, to models, to clinical decisions, bias compounds at every stage rather than staying contained.
Fairness vs. Accuracy Trade-offs
Improving fairness for one group can reduce performance for another, an unresolved optimization tension, not a solved problem.

What This Means in Practice

The consequences extend past model performance metrics: patient safety risks from misdiagnosis or delayed treatment, amplification of existing health disparities, regulatory exposure under anti-discrimination law, and erosion of trust among both clinicians and patients. Surveys consistently show a majority of patients remain uncomfortable with AI-driven healthcare decisions, a reasonable response given the pattern above.

For the institutional side of this, specifically how health systems are actually responding, what governance looks like in practice, and a concrete mitigation framework, see our companion piece, How to Mitigate AI Bias in Healthcare Systems.

Built With Oversight in Mind

Documentation That Keeps a Human in the Loop

HosTalky's AI Scribe is designed around clinician review, not blind automation, so the tools you use daily don't become another source of unexamined bias.

See How AI Scribe Works

The Bottom Line

None of these 7 cases involve a model that was designed to be biased. Each one reflects a system trained on real-world healthcare data that was already unequal, hardware calibrated on a narrow population, or a natural human tendency to trust automated output. AI doesn't introduce bias into healthcare; it reveals, scales, and operationalizes bias that was already there. The relevant question for any health system isn't whether bias exists in their AI tools, but how visible it is, how measurable it is, and how responsibly it's being managed.

FAQs

What is the most well-known example of AI bias in healthcare?
The most widely cited case is a risk-prediction algorithm, studied in a landmark 2019 Science paper, that used healthcare cost as a proxy for illness severity. Because Black patients historically incurred lower costs for the same level of illness, the algorithm systematically prioritized healthier white patients over sicker Black patients. Replacing cost with direct health indicators increased the share of Black patients flagged for extra care from 17.7% to 46.5%.
Does removing race from AI training data prevent bias?
No. Bias can emerge even when race is explicitly excluded, because proxy variables like healthcare cost, ZIP code, or historical treatment patterns can encode race implicitly. The Optum risk-prediction case demonstrated this directly: the algorithm never used race as an input, but still produced racially biased outcomes.
Is AI bias in healthcare only a data problem?
No. Bias also enters through hardware, as with pulse oximeters that overestimate blood oxygen in patients with darker skin, and through human behavior, as with automation bias, where clinicians over-trust AI recommendations and reduce their own critical evaluation. Bias compounds across sensors, datasets, models, and clinical decisions.
Can AI bias in healthcare be fully eliminated?
Not realistically. Improving fairness for one group can reduce accuracy for another, which makes bias mitigation a matter of managing trade-offs responsibly rather than eliminating bias entirely. This requires normative decisions about acceptable risk distribution, not just technical fixes.

Sources and References

  1. Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464). science.org
  2. Daneshjou, R., et al. (2021). Lack of transparency and potential bias in artificial intelligence data sets and algorithms: a scoping review. The Lancet Digital Health. thelancet.com
  3. Pharmacogenomics of warfarin dosing across populations. pmc.ncbi.nlm.nih.gov
  4. UK Government. (2024). Equity in Medical Devices: Independent Review. gov.uk
  5. Rutgers University-Newark. (2024). AI Algorithms Used in Healthcare Can Perpetuate Bias, citing Payton, F.C., et al., The Milbank Quarterly. rutgers.edu
  6. Cedars-Sinai Medical Center. (2025). Cedars-Sinai Study Shows Racial Bias in AI-Generated Treatment Regimens for Psychiatric Patients. cedars-sinai.org
Hanna Mae Rico

Written by

Hanna Mae Rico

Hanna Mae Rico is a healthcare communications writer covering clinical operations, patient safety, and the systems shaping frontline care delivery. Her work focuses on translating complex healthcare communication challenges into practical insights for nurses, hospital leaders, and clinical teams navigating high-pressure care environments.

View all articles by Hanna ->